According to a new report from Intel Market Research, the global DNA/RNA Non-Specific Endonuclease market was valued at USD 78.5 million in 2024 and is projected to reach USD 183 million by 2031, growing at an impressive CAGR of 13.9% during the forecast period (2025-2031). This expansion is driven by accelerating applications in genomics, pharmaceutical research, and molecular diagnostics, where these enzymes play a critical role in nucleic acid processing.
Read MoreAccording to new market analysis from Intel Market Research, the global Nonspecific Universal Nuclease market was valued at USD 77.6 million in 2024 and is projected to reach USD 179 million by 2031, expanding at an accelerated CAGR of 13.9% during the forecast period (2025-2031). This remarkable growth trajectory stems from escalating demand in biopharmaceutical manufacturing, vaccine production, and molecular biology research applications where nucleic acid removal is critical.
Read MoreAccording to a new report from Intel Market Research, the global Intelligent Parallel Bioreactor market was valued at USD 317 million in 2024 and is projected to reach USD 508 million by 2031, growing at a CAGR of 7.4% during the forecast period (2024–2031). This growth trajectory reflects the increasing adoption of high-throughput bioprocessing solutions across pharmaceutical development, environmental biotechnology, and academic research sectors.
Read MoreAccording to a new report from Intel Market Research, the global Bedsore Wound Dressing market was valued at USD 713 million in 2024 and is projected to reach USD 913 million by 2031, growing at a CAGR of 3.7% during the forecast period (2025–2031). This growth is driven by increasing geriatric populations, rising prevalence of chronic diseases requiring prolonged bed rest, and advancements in wound care technologies.
Read MoreAccording to the latest market analysis from Intel Market Research, the global Lightweight Lead Curtains market was valued at USD 216 million in 2024 and is projected to reach USD 316 million by 2031, expanding at a steady CAGR of 5.9% during the forecast period (2024-2031). This growth trajectory reflects increasing radiation safety regulations across healthcare, nuclear, and industrial sectors worldwide, coupled with technological advancements in radiation shielding materials.
Read More